Spranger and colleagues found that in both humans and mice, melanoma tumors with active β-catenin reduce CC-chemokine ligand 4 (CCL4) expression which resulted in lower conventional DC type 1 (cDC1) infiltration and increased tumor growth (81). Here, MPPE1 is linked to neoplasm.